NAPLEX Psychiatric Therapeutics Practice Questions with Answers

Mastering NAPLEX Psychiatric Therapeutics requires a deep understanding of psychopharmacology, including mechanisms of action, side effect profiles, and monitoring parameters for conditions like depression, schizophrenia, and bipolar disorder. This guide provides comprehensive practice questions and explanations to help you navigate the complexities of mental health medications and clinical decision-making.

Concept Explanation

NAPLEX Psychiatric Therapeutics involves the clinical application of pharmacological principles to treat mental health disorders, focusing on optimizing efficacy while minimizing adverse drug reactions and significant drug-drug interactions. The core of this discipline lies in understanding the neurotransmitter systems—primarily serotonin, norepinephrine, dopamine, and GABA—and how various medication classes modulate them. For instance, Selective Serotonin Reuptake Inhibitors (SSRIs) are first-line for depression, but clinicians must monitor for serotonin syndrome and suicidal ideation. Antipsychotics, particularly second-generation agents, require metabolic monitoring for weight gain and dyslipidemia, a topic frequently covered in NAPLEX CNS Pharmacology Practice Questions. Success on the exam depends on your ability to select the appropriate agent based on patient-specific factors, such as age, comorbidities, and pregnancy status, as outlined in the NAPLEX Prep hub.

Solved Examples

1. Example 1: SSRI Washout Period
   A patient is being switched from fluoxetine to phenelzine (an MAOI). How long must the patient wait after stopping fluoxetine before starting phenelzine?
   1. Identify the half-life of fluoxetine: Fluoxetine has a very long half-life (4–6 days) and its active metabolite, norfluoxetine, lasts even longer.
   2. Apply the safety rule: To prevent serotonin syndrome, a 5-week washout period is required for fluoxetine.
   3. Conclusion: The patient must wait 5 weeks.
2. Example 2: Lithium Clearance
   A patient with a baseline creatinine clearance (CrCl) of 80 mL/min starts lithium. If their CrCl drops to 40 mL/min due to dehydration, what happens to the lithium levels?
   1. Recognize lithium kinetics: Lithium is 100% renally cleared and is handled similarly to sodium in the kidneys.
   2. Determine the relationship: Decreased renal clearance leads to decreased excretion of lithium.
   3. Conclusion: Lithium levels will increase, potentially reaching toxic levels (typically $> 1.5 \text{ mEq/L}$).
3. Example 3: Clozapine Monitoring
   A patient on clozapine presents with an Absolute Neutrophil Count (ANC) of $900/ \text{mm}^3$. What is the appropriate clinical action?
   1. Check the REMS requirements: Clozapine requires regular ANC monitoring due to the risk of agranulocytosis.
   2. Compare the value: An ANC $< 1000/ \text{mm}^3$ is considered severe neutropenia.
   3. Conclusion: Interrupt clozapine therapy and monitor ANC daily until it returns to $> 1000/ \text{mm}^3$.

Practice Questions

1. A 28-year-old female patient with Major Depressive Disorder (MDD) is prescribed sertraline. She expresses concern about weight gain and sexual dysfunction. Which antidepressant is least likely to cause these specific side effects?
2. Which second-generation antipsychotic (SGA) is associated with the highest risk of QT interval prolongation?
3. A patient taking valproic acid for bipolar disorder presents with a tremor, hair loss, and easy bruising. Which laboratory test is most important to order immediately to assess for serious toxicity?

4. A patient on a stable dose of lithium is started on lisinopril for hypertension. What is the expected effect on the patient's lithium serum concentration?
5. Which of the following benzodiazepines is preferred in an elderly patient with hepatic impairment: diazepam, alprazolam, lorazepam, or chlordiazepoxide?
6. A patient is experiencing acute dystonia after their first dose of haloperidol. What is the first-line treatment for this extrapyramidal symptom (EPS)?
7. When counseling a patient on the use of zolpidem (Ambien) for insomnia, what is the most critical safety warning regarding complex sleep behaviors?
8. A patient with schizophrenia has failed two separate trials of SGAs (risperidone and quetiapine). What is the next most appropriate pharmacological step according to clinical guidelines?
9. Which antidepressant requires a strict tyramine-free diet to avoid a hypertensive crisis?
10. A patient taking paroxetine and tramadol is brought to the ED with hyperreflexia, tremors, and a temperature of $102.5^\circ \text{F}$. What is the most likely diagnosis?

Answers & Explanations

1. Bupropion: Bupropion does not affect serotonin and is known for having a low risk of sexual dysfunction and weight gain. In fact, it may lead to modest weight loss. For more on metabolic side effects, see NAPLEX Endocrine Pharmacology Practice Questions.
2. Ziprasidone: Among the SGAs, ziprasidone carries a boxed warning for QT prolongation. It should be avoided in patients with a history of long QT syndrome or recent myocardial infarction. This is a common theme in NAPLEX Cardiovascular Pharmacology Practice Questions.
3. Liver Function Tests (LFTs) and Platelets: Valproic acid can cause hepatotoxicity (elevated LFTs) and thrombocytopenia (low platelets), which explains the bruising. Tremor and alopecia are common but less life-threatening side effects.
4. Increase: ACE inhibitors like lisinopril decrease the clearance of lithium by the kidneys, leading to increased lithium levels and potential toxicity.
5. Lorazepam: For patients with liver issues, use the "LOT" drugs (Lorazepam, Oxazepam, Temazepam) because they undergo direct glucuronidation and do not have active metabolites.
6. Benztropine or Diphenhydramine: Acute dystonia is treated with anticholinergic medications administered IM or IV for rapid relief.
7. Parasomnias: Zolpidem has a boxed warning for complex sleep behaviors like sleep-walking, sleep-driving, and preparing food while asleep, which can result in serious injury or death.
8. Clozapine: Clozapine is indicated for treatment-resistant schizophrenia, defined as failing two or more adequate trials of other antipsychotics.
9. Phenelzine (or other MAOIs): Monoamine oxidase inhibitors prevent the breakdown of tyramine; high levels of tyramine can cause a massive release of norepinephrine, leading to a hypertensive crisis.
10. Serotonin Syndrome: The combination of an SSRI (paroxetine) and a drug with serotonergic properties (tramadol) can lead to this life-threatening condition characterized by neuromuscular excitability and autonomic instability.

1. Which medication is a preferred first-line treatment for a pregnant patient with MDD?

• AParoxetine
• BSertraline
• CPhenelzine
• DLithium

Frequently Asked Questions

What is the difference between Serotonin Syndrome and NMS?

Serotonin Syndrome is caused by excess serotonin and features hyperreflexia and rapid onset, whereas Neuroleptic Malignant Syndrome (NMS) is caused by dopamine blockade and features "lead-pipe" muscle rigidity and a slower onset. Both conditions present with high fever and autonomic instability, but their neuromuscular findings are distinct. You can use the AI Flashcard Generator to help memorize these key differences.

Why is Paroxetine avoided in pregnancy?

Paroxetine is generally avoided during pregnancy because it has been linked to an increased risk of cardiac malformations in the fetus, specifically ventricular septal defects. Most other SSRIs are considered safer options if medication is necessary during gestation. For more details, consult the FDA website on pregnancy categories.

Which antidepressants have the highest risk of withdrawal symptoms?

Antidepressants with short half-lives, such as paroxetine and venlafaxine, carry the highest risk of discontinuation syndrome if stopped abruptly. Symptoms include dizziness, nausea, and "brain zaps," necessitating a gradual taper over several weeks. You can further explore this in NAPLEX Pharmacology Practice Questions.

What monitoring is required for patients on Valproic Acid?

Patients on valproic acid require regular monitoring of serum drug levels (target 50–125 mcg/mL), liver function tests (LFTs) due to hepatotoxicity risk, and complete blood counts (CBC) to check for thrombocytopenia. It is also important to monitor for signs of pancreatitis and hyperammonemia as per MedlinePlus guidelines.

How do you manage a patient with lithium toxicity?

Management of lithium toxicity involves aggressive hydration with normal saline to enhance renal excretion; however, if levels exceed $4.0 \text{ mEq/L}$ (or $2.5 \text{ mEq/L}$ with severe symptoms), hemodialysis is the definitive treatment. Clinicians must also stop all offending agents, including diuretics and NSAIDs that may be contributing to the elevation.